REAL-WORLD TREATMENT PATTERNS OF OMALIZUMAB IN CHRONIC IDIOPATHIC/SPONTANEOUS URTICARIA (CIU/CSU) PATIENTS IN THE UNITED STATES

被引：0
|
作者：
Eghrari-Sabet, J.
Sher, E.
Lefebvre, P.
Pilon, D.
Zhdanava, M.
Balp, M.
Kavati, A.
Ortiz, B.
Bernstein, J.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2017年 / 119卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P162
引用
收藏
页码：S42 / S42
页数：1
相关论文
共 50 条
  • [1] Efficacy of omalizumab treatment for patients with chronic idiopathic urticaria (CIU)/chronic spontaneous urticaria (CSU) in Taiwan
    Yan, Che-Wen
    Cho, Yung-Tsu
    Chu, Chia-Yu
    DERMATOLOGICA SINICA, 2017, 35 (04) : 182 - 186
  • [2] Real-world use of omalizumab in patients with chronic idiopathic/spontaneous urticaria in the United States
    Eghrari-Sabet, Jacqueline
    Sher, Ellen
    Kavati, Abhishek
    Pilon, Dominic
    Zhdanava, Maryia
    Balp, Maria-Magdalena
    Lefebvre, Patrick
    Ortiz, Benjamin
    Bernstein, Jonathan A.
    ALLERGY AND ASTHMA PROCEEDINGS, 2018, 39 (03) : 191 - 200
  • [3] Omalizumab effectively reduces angioedema episodes in patients with chronic idiopathic/spontaneous urticaria (CIU/CSU)
    Staubach, P.
    Metz, M.
    Chapman-Rothe, N.
    Sieder, C.
    Braeutigam, M.
    Canvin, J.
    Maurer, M.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 18 - 18
  • [4] Real-World Treatment Patterns in Chronic Spontaneous Urticaria in the United States
    Balp, M. M.
    Geissbuhler, Y.
    Mcconnon, A.
    Gomme, J.
    Mckenna, S. J.
    Kohli, R.
    Soong, W.
    VALUE IN HEALTH, 2022, 25 (12) : S464 - S465
  • [5] OMALIZUMAB USE IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA: A REAL-WORLD SURVEY IN THE UNITED STATES
    Holden, M.
    Seetasith, A.
    Hetherington, J.
    Wrest, E.
    Keal, A.
    Salmon, P.
    Mosnaim, G.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2023, 131 (05) : S41 - S41
  • [6] Real-world treatment patterns and outcomes of omalizumab use in patients with chronic idiopathic urticaria
    Wang, Liya
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Paknis, Brandee
    Bernstein, Jonathan A.
    Beck, Lisa A.
    CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (01) : 35 - 39
  • [7] REAL-WORLD CHARACTERISTICS AND TREATMENT PATTERNS IN URTICARIA PATIENTS INITIATING OMALIZUMAB IN THE UNITED STATES
    Wang, L.
    Kavati, A.
    Ke, X.
    Wertz, D.
    Huang, Q.
    Willey, V.
    Stephenson, J.
    Ortiz, B.
    Bernstein, B. Paknis J.
    Beck, L.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S44 - S44
  • [8] Real-World Characteristics and Treatment Patterns in Patients with Urticaria Initiating Omalizumab in the United States
    Ke, Xuehua
    Kavati, Abhishek
    Wertz, Debra
    Huang, Qing
    Wang, Liya
    Willey, Vincent J.
    Stephenson, Judith J.
    Ortiz, Benjamin
    Paknis, Brandee
    Bernstein, Jonathan A.
    Beck, Lisa A.
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2018, 24 (07): : 598 - +
  • [9] A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium
    Lapeere, H.
    Baeck, M.
    Stockman, A.
    Sabato, V.
    Grosber, M.
    Moutschen, M.
    Lambert, J.
    Vandebuerie, L.
    de Montjoye, L.
    Rabijns, H.
    Allewaert, K.
    Schrijvers, R.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : 127 - 134
  • [10] Patient demographics and real-world use of omalizumab for the treatment of chronic spontaneous/idiopathic urticaria in Canada
    Sussman, Gordon L.
    Lacuesta, Gina A.
    Hebert, Jacques
    Kanani, Amin S.
    Rihakova, Lenka
    Chiva-Razavi, Sima
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2017, 139 (02) : AB246 - AB246
12345